Back to Trades
Kalofonos Isabel
Chief Commercial OfficerCIK 0001975163
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 2
- Buy transactions
- 0
- Sell transactions
- 1
- Companies
- 1
- Active
- 2026
Kalofonos Isabel, Chief Commercial Officer, has filed 2 SEC reports (2026), all concentrated in Crinetics Pharmaceuticals, Inc. (CRNX), totaling $9.7M in disclosed volume. Weighing $0 bought versus $137.5K sold, the history is heavily weighted toward selling. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
2 loaded
| Sep 1 | CRNX Crinetics Pharmaceuticals, Inc. | Kalofonos Isabel | Chief Commercial Officer | Disposed | $9.4M |
| Jan 7 | CRNX Crinetics Pharmaceuticals, Inc. | Kalofonos Isabel | Chief Commercial Officer | Sell | $137.5K |
2 filings